Sort
82,697 grants matching “vaccine development”
Genes for Tolerance and Immunity Consortium
$1,194,476Australian National University · R01 · FY2003 · AI
Macque
$1,194,109Francois J Villinger · Emory University · U19 · FY2011 · AI
Industrialization Core: Production of monoclonal antibodies and product developm
$1,193,970Larry Zeitlin · Scripps Research Institute, The · U19 · FY2014 · AI
Fungal Antigen Resources for Development of Vaccines and Diagnostics
$1,193,457Stuart M Levitz · Univ Of Massachusetts Med Sch Worcester · R24 · FY2025 · AI
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2
$1,193,360Michael S. Diamond · Washington University · R01 · FY2024 · AI
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
$1,193,309Michael S. Diamond · Washington University · R01 · FY2020 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,193,247Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
$1,193,174Daniel William Cramer · Brigham And Women'S Hospital · P50 · FY2009 · CA
Discovery and Targeting of West Nile Virus Epitopes
$1,193,045William Hildebrand · University Of Oklahoma Hlth Sciences Ctr · U01 · FY2010 · AI
Combinational Immunotherapies to Amplify Vaccine Induced
$1,193,000Johns Hopkins University · U19 · FY2005 · CA
Therapeutics for Pox, Filo and Other Viral Pathogens
$1,192,986Auburn University At Auburn · U19 · FY2004 · AI
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
$1,192,954Luis Manuel Branco · Zalgen Labs, Llc · R01 · FY2022 · AI
Microarrays and Macaque Influenza Model
$1,192,595Michael G Katze · Icahn School Of Medicine At Mount Sinai · P01 · FY2008 · AI
Screening and development of anti-Ebola entry inhibitors
$1,192,567Lijun Rong · University Of Illinois At Chicago · U01 · FY2009 · AI
Antiviral therapeutics for flavivirus infections
$1,192,443Dennis E. Hruby · Siga Technologies, Inc. · R01 · FY2015 · AI
Task A12: Testing of Candidate Vaccines Against Mycobacterium Tuberculosis
$1,192,349Colorado State University · N01 · FY2012 · AI
Transforming Clinical and Translational Research and Education at Rockefeller
$1,192,282Barry Coller · Rockefeller University · KL2 · FY2010 · RR
Influenza Viral Pathogenesis
$1,192,237Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Impact of novel enhancers on Igh repertoire diversity
$1,191,324Amy L. Kenter · University Of Illinois At Chicago · R01 · FY2025 · AI
DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE
$1,191,222St. Jude Children'S Research Hospital · P01 · FY2003 · AI
Structural Biology of Influenza Epitopes
$1,190,928Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Synthesis of Therapeutic Agents for Treatment of Infectious Diseases
$1,190,876John Givens · Starks Associates, Inc. · N01 · FY2019 · AI
Spirulina oral supplement for enhancing host resilience to virus infection
$1,190,663Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2020 · AT
Dimandelic Acid Ethers As Topical Microbicides For HIV
$1,190,534Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · HD
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,190,453Adriana H Tremoulet · University Of California, San Diego · P50 · FY2025 · HD